UHPLC‐DAD‐ESI‐MS/MS and HPTLC profiling of ash leaf samples from different commercial and natural sources and their in vitro effects on mediators of inflammation
Introduction In European traditional medicine, common ash leaf infusion is recommended by European Medicines Agency to treat minor articular pain and to increase the amount of urine for flushing minor urinary complaints. However, a comprehensive ultra‐high‐performance liquid chromatography diode arr...
Saved in:
Published in | Phytochemical analysis Vol. 31; no. 1; pp. 57 - 67 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.01.2020
Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 0958-0344 1099-1565 1099-1565 |
DOI | 10.1002/pca.2866 |
Cover
Summary: | Introduction
In European traditional medicine, common ash leaf infusion is recommended by European Medicines Agency to treat minor articular pain and to increase the amount of urine for flushing minor urinary complaints. However, a comprehensive ultra‐high‐performance liquid chromatography diode array detector electrospray ionisation tandem mass spectrometry (UHPLC‐DAD‐ESI‐MS/MS) analysis of this pharmacopeial plant material has never been performed. Moreover, the number of biological and pharmacological investigations proving the usefulness of this plant material in recommended traditional uses is surprisingly small.
Objective
Phytochemical profiling of ash leaf samples from different commercial and natural sources and the determination of the in vitro effects on inflammatory mediators in a model of human neutrophils.
Methods
Ash leaf samples were characterised by total hydroxycinnamic acid content and by high‐performance thin layer chromatography (HPTLC), UHPLC‐DAD‐ESI‐MS/MS methods. The effects of leaf infusions on reactive oxygen species (ROS), tumor necrosis factor (TNF‐α), interleukin 8 (IL‐8), interleukin 1β (IL‐1β), and monocyte chemoattractant protein 1 (MCP‐1) production by neutrophils were measured using luminol‐dependent chemiluminescence and enzyme‐linked immunosorbent assay (ELISA).
Results
In ash leaf samples 64 compounds were identified or partly identified together with four unknown compounds. The major compounds detected belong to different structural groups, including phenolic acid derivatives, phenylethanoids, flavonoids, iridoids, secoiridoids and lignans. The major compounds detected in ash samples were chlorogenic acid, quercetin‐3‐O‐rutinoside, verbascoside, oleuropein and ligstroside. However, one sample contained coumarin derivatives. This finding suggested adulteration with other Fraxinus species and/or plant parts. All infusions were able to inhibit ROS, cytokine and chemokine production.
Conclusions
The performed phytochemical and biological analyses contribute to the knowledge about this pharmacopeial plant material and supports its traditional use to treat minor inflammatory complaints.
In ash leaf samples 64 compounds were identified or partly identified together with 4 unknown compounds. The compounds detected belong to different structural groups, including phenolic acid derivatives, phenylethanoids, flavonoids, iridoids, secoiridoids and lignans. The major compounds detected in ash samples were chlorogenic acid, quercetin‐3‐Orutinoside, verbascoside, oleuropeinand ligstroside. However, one sample contained coumarin derivatives. This finding suggested adulteration with other Fraxinus species and/or plant parts. All infusions were able to inhibit reactive oxygenspecies, cytokine and chemokine production. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0958-0344 1099-1565 1099-1565 |
DOI: | 10.1002/pca.2866 |